According to a new report, published by KBV research, The Global Tangential Flow Filtration Market size is expected to reach $3.5 billion by 2028, rising at a market growth of 10.9% CAGR during the forecast period.
The Nanofiltration & Others segment is showcasing a CAGR of 11.3% during (2022 - 2028). This technique is highly employed in selective ion separation and end-stage sterilization processes. The pore size of these filters lie between 1 and 10 nanometers. These membranes are efficient in removing proteins, microbes, organic compounds, and multivalent ions. Since only certain specific salts and water can pass through these membranes, these are highly adopted in drug filling and formulation processes.
The Membrane Filters segment is leading the Global Tangential Flow Filtration Market by Product in 2021 thereby, achieving a market value of $1.2 billion by 2028. The progressing implementation of this system across various industries are the main driving force behind the growth of the segment. Tangential flow filtration provides the accessibility to various types of filters, which increases their applicability in multiple processes. Membrane filters are being used to a great extent in the pharmaceutical industries owing to their improved accuracy, high throughput, less filtration time, less cross-contamination, and negligible membrane fouling.
The Vaccine & Viral Vectors segment has shown the growth rate of 11.4% during (2022 - 2028). The increased use of the TFF technology in the various downstream processes during the pandemic is accountable for the expansion of the segment. The automated TFF further increased the production and speed of vaccine manufacturing. TFF technology also provides low hold-up volume, facility flexibility, increased recovery of product, and reduced processing time.
The Pharmaceutical & Biotechnology Companies segment acquired maximum revenue share in the Global Tangential Flow Filtration Market by End-user in 2021 thereby, achieving a market value of $1.5 billion by 2028. The rising number of drug discovery initiatives and programs, treatment product in pipelines, and growing investments by market players to support the ongoing R&D activities are propelling the growth of the segment. Applications like concentration of molecules, cell harvesting, and viral vector recovery utilize the TFF technology.
The North America market dominated the Global Tangential Flow Filtration Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.4 billion by 2028. The Europe market is exhibiting a CAGR of 10.2% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 12% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/tangential-flow-filtration-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Parker Hannifin Corporation, Danaher Corporation, Sartorius Stedim Biotech S.A. (Sartorius AG), Merck Millipore (Merck Group), Alfa Laval AB, Repligen Corporation, Meissner Filtration Products, Inc., ABEC, Inc., Sterlitech Corporation, and Synder Inc.
By Technology
By Product
By Application
By End-User
Companies Profiled
Unique Offerings 
